Loading organizations...
Rellim Capital Management operates as a family investment firm, providing private wealth management services for enduring capital growth. The firm concentrates on building and preserving wealth across generations through strategic investments. Its capabilities span various asset classes, including private equity and venture capital, aiming to deliver long-term value and capital appreciation for its clients.
The firm's inception is closely associated with Jason Miller, whose surname, spelled backward, forms the company's name. While specific founding dates are not publicly detailed, Rellim Capital Management was established on the insight that family wealth requires dedicated stewardship and a generational perspective. Ben Graham also plays a significant role within the firm's leadership, contributing to its investment strategies and operational oversight.
Rellim Capital Management serves affluent families and individuals who prioritize the sustained growth and intergenerational transfer of their assets. The company's vision is rooted in its commitment to creating lasting value, ensuring capital is not only preserved but also grows robustly over the long term. It anticipates client needs to secure financial legacies for future generations.
Rellim Capital Management has 1 tracked investment across 1 company. The latest tracked deal is $270.0M Series A in Orbital Therapeutics in April 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2023 | Orbital Therapeutics | $270.0M Series A | ARCH Venture Partners | Andreessen Horowitz, Nextech Invest, Section 32, Versant Ventures, A16z BIO + Health, ABU Dhabi Growth Fund, Agent Capital, Alexandria Venture Investments, Casdin Capital, Exor, Heritage Medical Systems, IGlobe Partners, Invus, Newpath Partners, Redmile Group |